Bone Marrow Transplantation - Table of Contents alert Volume 53 Issue n8

If you are unable to see the message below, click here to view.

TABLE OF CONTENTS Volume 53, Issue 8 In this issue Comment Review Article Article Correspondence Also new AOP   Advertisement We are pleased to announce that the Impact Factor* for Bone Marrow Transplantation is now 4.497 - an increase of 16.1% from last year. Bone Marrow Transplantation is ranked 5 of 25 in the Transplantation category, 15 of 71 in the Hematology category, 61 of 222 Oncology category and 40 of 155 in the Immunology category. The journal would like to thank all our authors, reviewers and readers for their continued support.  Submit your research >>>  *2017 Journal Citation Reports (Clarivate Analytics, 2018)   Comment The big freeze may be over: a contracting universe for cryopreservation? Robert Peter Gale & Guillermo J. Ruiz-Argüelles Bone Marrow Transplantation 2018 53 :947 - 948; February 23, 2018; 10.1038/s41409-018-0119-3   Abstract | Full Text Review Article Selected biological issues affecting relapse after stem cell transplantation: role of T-cell impairment, NK cells and intrinsic tumor resistance Marcel van den Brink, Markus Uhrberg, Lorenz Jahn, John F. DiPersio & Michael A. Pulsipher Bone Marrow Transplantation 2018 53 :949 - 959; January 24, 2018; 10.1038/s41409-017-0078-0   Abstract | Full Text Article Advantages of non-cryopreserved autologous hematopoietic stem cell transplantation against a cryopreserved strategy M. Sarmiento, P. Ramírez, R. Parody, MQ. Salas, N. Beffermann et al. Bone Marrow Transplantation 2018 53 :960 - 966; February 13, 2018; 10.1038/s41409-018-0117-5   Abstract | Full Text Satisfaction with sexual activity and sexual dysfunction in hematopoietic stem cell transplantation survivors and their partners: a couple study Kwai Han Yoo, Danbee Kang, Im-Ryung Kim, Eun-Kyung Choi, Jin Seok Kim et al. Bone Marrow Transplantation 2018 53 :967 - 976; February 05, 2018; 10.1038/s41409-018-0097-5   Abstract | Full Text Thyroid dysfunction in adult hematopoietic cell transplant survivors: risks and outcomes Nosha Farhadfar, Marius N. Stan, Pankaj Shah, Vikram Sonawane, Mehrdad T. Hefazi et al. Bone Marrow Transplantation 2018 53 :977 - 982; February 06, 2018; 10.1038/s41409-018-0109-5   Abstract | Full Text Cardiovascular risk factors and subclinical organ damage after hematopoietic stem cell transplantation in pediatric age Bianca Borchert-Mörlins, Nima Memaran, Martin Sauer, Britta Maecker-Kolhoff, Karl-Walter Sykora et al. Bone Marrow Transplantation 2018 53 :983 - 992; February 09, 2018; 10.1038/s41409-018-0104-x   Abstract | Full Text Stem cell transplantation for T-cell lymphomas in Taiwan Ya-Ting Hsu, Hui-Jen Tsai, Jeffrey S. Chang, Sin-Syue Li, Jih-Luh Tang et al. Bone Marrow Transplantation 2018 53 :993 - 1000; February 12, 2018; 10.1038/s41409-018-0116-6   Abstract | Full Text Autologous stem cell transplantation for primary mediastinal B-cell lymphoma: long-term outcome and role of post-transplant radiotherapy. A report of the European Society for Blood and Marrow Transplantation Irit Avivi, Ariane Boumendil, Hervé Finel, Arnon Nagler, Aïda Botelho de Sousa et al. Bone Marrow Transplantation 2018 53 :1001 - 1009; February 20, 2018; 10.1038/s41409-017-0063-7   Abstract | Full Text A randomized, placebo-controlled pilot trial of aprepitant combined with standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting in patients undergoing cyclophosphamide-based conditioning regimens prior to hematopoietic stem cell transplant (HSCT) Joseph Bubalo, Kelsey Mulverhill, Gabrielle Meyers, Brandon Hayes-Lattin & Richard Maziarz Bone Marrow Transplantation 2018 53 :1010 - 1018; February 20, 2018; 10.1038/s41409-018-0106-8   Abstract | Full Text The putative anti-leukemic effects of anti-thymocyte globulins in patients with CD7-positive acute myeloid leukemia Kiyosumi Ochi, Shigeo Fuji, Kuniko Takano, Kinuko Tajima, Ayumu Ito et al. Bone Marrow Transplantation 2018 53 :1019 - 1029; February 19, 2018; 10.1038/s41409-018-0115-7   Abstract | Full Text Variability of nutritional practices in peritransplant period after allogeneic hematopoietic stem cell transplantation: a survey by the Complications and Quality of Life Working Party of the EBMT Zinaida Peric, Stefano Botti, Jacqui Stringer, Joanna Krawczyk, Steffie van der Werf et al. Bone Marrow Transplantation 2018 53 :1030 - 1037; March 07, 2018; 10.1038/s41409-018-0137-1   Abstract | Full Text Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial Heather S. L. Jim, Steven Sutton, Navneet S. Majhail, William A. Wood, Paul B. Jacobsen et al. Bone Marrow Transplantation 2018 53 :1038 - 1043; March 07, 2018; 10.1038/s41409-018-0138-0   Abstract | Full Text Correspondence Rituximab for second desensitization in patients with rebound of donor-specific anti-HLA antibodies before T-replete haplo-transplant using high-dose post-transplant cyclophosphamide Alice Garnier, Florent Delbos, Thierry Guillaume, Pierre Peterlin, Amandine Le Bourgeois et al. Bone Marrow Transplantation 2018 53 :1044 - 1047; February 01, 2018; 10.1038/s41409-018-0107-7   Abstract | Full Text Chronic graft versus host disease presenting as lichen planus pigmentosus Pauline Tétu, Marie Jachiet, Adèle de Masson, Charlotte Hurabielle, Michel Rybojad et al. Bone Marrow Transplantation 2018 53 :1048 - 1050; February 06, 2018; 10.1038/s41409-018-0110-z   Abstract | Full Text BEAM vs FEAM high-dose chemotherapy: retrospective study in lymphoma patients undergoing autologous stem cell transplant F. Marchesi, S. Capria, D. Giannarelli, S. M. Trisolini, M. Ansuinelli et al. Bone Marrow Transplantation 2018 53 :1051 - 1054; February 13, 2018; 10.1038/s41409-018-0120-x   Abstract | Full Text Is there expert consensus on expert consensus? Giovanni Barosi & Robert Peter Gale Bone Marrow Transplantation 2018 53 :1055 - 1060; February 28, 2018; 10.1038/s41409-018-0128-2   Abstract | Full Text Gut decontamination during allogeneic hematopoietic stem cell transplantation and the risk of acute graft-versus-host disease Lars K. Gjærde, Mette Schmidt & Henrik Sengeløv Bone Marrow Transplantation 2018 53 :1061 - 1064; February 28, 2018; 10.1038/s41409-018-0131-7   Abstract | Full Text Severe pembrolizumab-associated neutropenia after CD34+ selected allogeneic hematopoietic-cell transplantation for multiple myeloma Adam R Bryant, Miguel-Angel Perales, Roni Tamari, Jonathan U Peled & Sergio Giralt Bone Marrow Transplantation 2018 53 :1065 - 1068; March 07, 2018; 10.1038/s41409-018-0142-4   Abstract | Full Text Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples Armin Rashidi, Ryan Shanley, Sophia L. Yohe, Bharat Thyagarajan, Julie Curtsinger et al. Bone Marrow Transplantation 2018 53 :1069 - 1071; March 07, 2018; 10.1038/s41409-018-0127-3   Abstract | Full Text Impact of T-cell depletion on outcome of patients undergoing allogeneic hematopoietic cell transplantation for myelodysplastic syndrome Maude Raboud, Yan Beauverd, Federico Simonetta, Carole Dantin, Amandine Pradier et al. Bone Marrow Transplantation 2018 53 :1072 - 1075; March 07, 2018; 10.1038/s41409-018-0136-2   Abstract | Full Text Matched unrelated donor transplantation in glycogen storage disease type 1b patient corrects severe neutropenia and recurrent infections Lubna S. Mehyar, Rolla Abu-Arja, Hemalatha G. Rangarajan, Vinita Pai, Dennis W. Bartholomew et al. Bone Marrow Transplantation 2018 53 :1076 - 1078; March 07, 2018; 10.1038/s41409-018-0147-z   Abstract | Full Text Prevalence of self-reported sleep dysfunction before allogeneic hematopoietic cell transplantation Anita D’Souza, Heather Millard, Jennifer Knight, Ruta Brazauskas, Stephanie J Lee et al. Bone Marrow Transplantation 2018 53 :1079 - 1082; March 07, 2018; 10.1038/s41409-018-0150-4   Abstract | Full Text Epithelial barrier dysfunction as permissive pathomechanism in human intestinal graft-versus-host disease Hanno Troeger, Nina A. Hering, Christian Bojarski, Anja Fromm, Christian Barmeyer et al. Bone Marrow Transplantation 2018 53 :1083 - 1086; March 09, 2018; 10.1038/s41409-018-0144-2   Abstract | Full Text Advertisement Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours. Click here to sign up. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Bone Marrow Transplantation. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Springer Nature's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.